ProfessionalDiscontinued

Paul Grof, MD, FRCPC Endorses Healthcare Practitioner Access to Psilocybin for Professional Training

TheraPsil’s page presents a letter from Paul Grof, MD, FRCPC supporting healthcare practitioner access to psilocybin for professional training. It explains the need for trained clinicians in psilocybin-assisted psychotherapy and the role of experiential learning in that training model.

Provider

English

Details

60 years

Enrollment

Price on request
This course is currently marked as discontinued.

Course Overview

This course page centers on a public letter from Paul Grof, MD, FRCPC, supporting healthcare practitioner access to psilocybin for professional training. The source text describes psilocybin-assisted psychotherapy as a modality that requires specific preparation and familiarity with non-ordinary states of consciousness. The page explains TheraPsil’s training approach, which combines lectures, case studies, readings, discussions, and experiential learning. In the described model, trainees include doctors, therapists, clinical counselors, nurses, social workers, and other healthcare professionals who may participate in psilocybin-assisted psychotherapy training. The page also provides background on TheraPsil’s efforts to secure exemptions for professional training and the shortage of qualified healthcare professionals in this area. It is a professional education resource focused on training rationale and access rather than a detailed standalone syllabus.

Who is this for?

Healthcare professionals involved in psilocybin-assisted psychotherapy, including doctors, therapists, clinical counselors, nurses, and social workers.

Prerequisites

Not stated.

About the Provider

TheraPsil is a Canadian grassroots nonprofit advancing compassionate, legal access to psilocybin-assisted psychotherapy through clinician training, patient advocacy, and legal reform, having trained over 700 healthcare professionals since 2019. The organization assists Canadians in navigating Health Canada's Special Access Program, supports patient-rights litigation in Federal Court, and operates the PsilWell community-funded clinical trial exploring psilocybin-assisted therapy for general wellbeing.

View Therapsil profile

Course Details

  • PricePrice on request
  • Lifecycle statusDiscontinued
  • Skills
    IntegrationPsychotherapyPsilocybin TherapyUnderstanding psilocybin-assisted psychotherapyPreparing for psychedelic-supported psychotherapySupporting patients in non-ordinary states of consciousnessRecognizing when to intervene and when not to interveneFacilitating post-integration sessionsApplying experiential learning to clinical trainingPsilocybin-assisted psychotherapy fundamentalsUnderstanding non-ordinary states of consciousnessTherapeutic preparation and supervisionPost-session integration conceptsProfessional training rationale for healthcare practitioners
  • Categories